The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(6-(methylamino)pyrazin-2-yl)-N-(4-(4-methylpiperazin-1-yl)phenyl)-4-phenoxy-7H-pyrrolo[2,3-d]pyrimidin-2-amine ID: ALA4540819
PubChem CID: 155550586
Max Phase: Preclinical
Molecular Formula: C28H29N9O
Molecular Weight: 507.60
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CNc1cncc(-c2c[nH]c3nc(Nc4ccc(N5CCN(C)CC5)cc4)nc(Oc4ccccc4)c23)n1
Standard InChI: InChI=1S/C28H29N9O/c1-29-24-18-30-17-23(33-24)22-16-31-26-25(22)27(38-21-6-4-3-5-7-21)35-28(34-26)32-19-8-10-20(11-9-19)37-14-12-36(2)13-15-37/h3-11,16-18H,12-15H2,1-2H3,(H,29,33)(H2,31,32,34,35)
Standard InChI Key: KIQPGNPOPVJIBS-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 43 0 0 0 0 0 0 0 0999 V2000
42.4719 -2.2864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4707 -3.1060 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.1788 -3.5149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1770 -1.8776 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.8856 -2.2828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8904 -3.1015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.6705 -3.3499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.1478 -2.6848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.6627 -2.0254 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.7641 -1.8780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.0565 -2.2868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3488 -1.8766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6417 -2.2847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6414 -3.1028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3542 -3.5110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0584 -3.1006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9343 -3.5125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.1798 -4.3321 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.4727 -4.7416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2276 -3.1009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5226 -3.5071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5197 -4.3246 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.2279 -4.7343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9390 -4.3264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7677 -4.3334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0610 -4.7422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0616 -5.5603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7748 -5.9678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4786 -5.5566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.9262 -4.1210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.3812 -4.7314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.6377 -5.5065 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
45.4387 -5.6724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.9828 -5.0570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.7235 -4.2843 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
46.7837 -5.2195 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
47.0435 -5.9943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8110 -4.7316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
1 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
14 17 1 0
3 18 1 0
18 19 1 0
17 20 1 0
17 24 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
19 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 19 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 30 1 0
7 30 1 0
34 36 1 0
36 37 1 0
22 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 507.60Molecular Weight (Monoisotopic): 507.2495AlogP: 4.74#Rotatable Bonds: 7Polar Surface Area: 107.12Molecular Species: NEUTRALHBA: 9HBD: 3#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 10.86CX Basic pKa: 7.81CX LogP: 4.35CX LogD: 3.65Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.29Np Likeness Score: -1.14
References 1. Tang G, Liu L, Wang X, Pan Z.. (2019) Discovery of 7H-pyrrolo[2,3-d]pyrimidine derivatives as selective covalent irreversible inhibitors of interleukin-2-inducible T-cell kinase (Itk)., 173 [PMID:30999237 ] [10.1016/j.ejmech.2019.03.055 ]